All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Webinar Review: FDA’s View on Compliance
On May 24, 2016, the American Association of Homeopathic Pharmacists hosted the latest in its Compliance through Education webinar series. The webinar featured a presentation...
FDA Guidance for Industry – Request for Quality Metrics
By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general,...
Homeopathic Drug Labels: Rx or OTC?
By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has...
Do Your Dosage Forms Appeal to Consumers?
By Eric L. Foxman, R.Ph. Consumers make purchase decisions based on several factors such as packaging and perceived effectiveness. Research shows dosage forms also factor...
Labeling homeopathic medicines for self-care
The U.S. Food and Drug Administration’s (FDA) electronic database of drug products contains more than 7,000 listings for over-the-counter (OTC) homeopathic products. The AAHP estimates...
Hatch, Paulsen Introduce Bill to Enhance HSA, FSA
In March, Senate Finance Committee Chairman Orrin Hatch (R-UT) and House Ways and Means Committee member, Rep. Erik Paulsen (R-MN) introduced the Health Savings Act...
Annual HPCUS Meeting Recap
In early April, the Homeopathic Pharmacopeia Convention of the United States (HPCUS) held its annual meeting. During the four-day event, multiple committees, the board, and...
